Sanjiv Patel
Chief Executive Officer bij RELAY THERAPEUTICS, INC.
Vermogen: 21 M $ op 29-02-2024
Profiel
Momenteel bekleedt Sanjiv K. Patel de functie van President, Chief Executive Officer & Director bij Relay Therapeutics, Inc. Hij is tevens lid van The Royal College of Surgeons of England. Dr. Patel bekleedde voorheen de functie van Chief Strategy Officer van Allergan Ltd. (Ierland). (Ierland). Hij behaalde een doctoraat aan de Universiteit van Londen, een MBA aan INSEAD en een graduaatsdiploma aan de Universiteit van Cambridge.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
RELAY THERAPEUTICS, INC.
1.62% | 16-01-2024 | 2 125 925 ( 1.62% ) | 21 M $ | 29-02-2024 |
PROTHENA CORP. PLC
-.--% | 06-03-2023 | 0 ( -.--% ) | - $ | 29-02-2024 |
Actieve functies van Sanjiv Patel
Bedrijven | Functie | Begin |
---|---|---|
RELAY THERAPEUTICS, INC. | Chief Executive Officer | 01-03-2017 |
ARYA SCIENCES ACQUISITION CORP V | Director/Board Member | 01-07-2021 |
The Royal College of Surgeons of England | Corporate Officer/Principal | - |
Eerdere bekende functies van Sanjiv Patel
Bedrijven | Functie | Einde |
---|---|---|
PROTHENA CORPORATION PLC | Director/Board Member | 01-07-2023 |
ALLERGAN PLC | Corporate Officer/Principal | 01-03-2017 |
ALLERGAN, INC. | Corporate Officer/Principal | 01-01-2017 |
Opleiding van Sanjiv Patel
University of Cambridge | Graduate Degree |
University of London | Doctorate Degree |
INSEAD | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
PROTHENA CORPORATION PLC | Health Technology |
RELAY THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Allergan, Inc.
Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
ARYA Sciences Acquisition Corp. V
ARYA Sciences Acquisition Corp. V Financial ConglomeratesFinance Arya Sciences Acquisition Corp. V is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Adam Stones, Joseph Eric Edelman, Michael R. Altman, and Konstantin Poukalov on February 22, 2021 and is headquartered in New York, NY. | Finance |